To examine the diagnosis, management, and treatment of conjunctivitis, Azari and Barney conducted a literature review of articles on both infectious and noninfectious conjunctivitis.
Chatterjee and coauthors performed a meta-analysis to determine benefits and risks associated with thrombolytic therapy vs anticoagulation in acute pulmonary embolism, including the subset of hemodynamically stable patients with right ventricular dysfunction. In an Editorial, Beckman discusses how to assess the net clinical benefit of thrombolysis for patients with pulmonary embolism.
Lincoff and coauthors determine whether addition of aleglitazar to standard medical therapy reduces cardiovascular morbidity and mortality among 7226 patients with type 2 diabetes mellitus (T2D) and a recent acute coronary syndrome (ACS).
This randomized clinical trial compares the effects of use vs nonuse of a cerebral embolic protection device during transcatheter aortic valve implantation (TAVI) on MRI-detected brain lesions in patients with severe aortic stenosis undergoing TAVI.
Kohli and coauthors review the safety, efficacy, and tolerability of current approved interferon-based regimens and oral interferon-free regimens for treating hepatitis C virus infection and provide treatment recommendations for specialists and generalists based on published evidence.
This JAMA Clinical Guidelines Synopsis summarizes the UK National Clinical Guideline Centre’s 2015 guideline on transfusion of red blood cells.
This Viewpoint discusses the yellow fever epidemic in Angola as well as in China, the Democratic Republic of Congo, and Kenya due to cases arising from infected travelers from Angola.